CALLIE RUDY: Open Payments
NPI 1578219309 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,020 in 206 payments from 23 companies in 2025. Trend: 2023 $2,714 · 2024 $4,652 · 2025 $5,020
Food & beverage: $5,020
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 28 | $908 |
| AOP Health US, LLC | 2 | $633 |
| Novartis Pharmaceuticals Corporation | 33 | $494 |
| Actelion Pharmaceuticals US, Inc. | 13 | $329 |
| PFIZER INC. | 17 | $285 |
| CVRx, Inc. | 10 | $285 |
| United Therapeutics Corporation | 9 | $264 |
| E.R. Squibb & Sons, L.L.C. | 24 | $235 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $222 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 8 | $217 |
Products named: Rapiblyk, LEQVIO, Barostim Neo System, UPTRAVI, WAINUA, LifeVest, FARXIGA, ELIQUIS.
Industry payments across FL — which companies pay providers there.
